⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TRDA News
Entrada Therapeutics, Inc. Common Stock
Entrada Therapeutics to Present at Upcoming Investor Conferences
globenewswire.com
TRDA
Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases
globenewswire.com
TRDA
Entrada Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
TRDA
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
TRDA
Entrada Therapeutics Reports Third Quarter 2025 Financial Results
globenewswire.com
TRDA
Entrada Therapeutics to Present at Upcoming Investor Conferences
globenewswire.com
TRDA